InvestorsHub Logo
Followers 36
Posts 3730
Boards Moderated 0
Alias Born 07/08/2002

Re: $5.95akadawson-m post# 96194

Saturday, 03/30/2019 8:24:03 AM

Saturday, March 30, 2019 8:24:03 AM

Post# of 108192
Conclusions: ADXS-PSA ± pembro elicited a broad antitumor T cell response in all mCRPC pts tested but only ADXS-PSA + pembro reduced PSA ≥50% from BL and prolonged OS in these select pts.


Clinical trial information: NCT02325557
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News